To achieve bladder cancer-specific suicide gene therapy, we inserted the UPII promotor and HSV-TK gene into a shuttle plasmid to generate the plasmid p-UPII-TK (Figure 1C). This evidence concerns the gene UPK2 and urinary bladder carcinoma.